[
    [
        {
            "time": "2021-12",
            "original_text": "重磅！国产新冠中和抗体药来了，引爆数百亿元市场",
            "features": {
                "keywords": [
                    "新冠",
                    "中和抗体药",
                    "市场"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "重磅！国产新冠中和抗体药来了，引爆数百亿元市场",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-12",
            "original_text": "2021年12月投资月报：医保控费走向精细化 差异化是企业发展策略",
            "features": {
                "keywords": [
                    "医保控费",
                    "精细化",
                    "差异化",
                    "企业策略"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2021年12月投资月报：医保控费走向精细化 差异化是企业发展策略",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-12",
            "original_text": "新股速递｜凯莱英6821明挂牌 暗盘早段跌5%报368.6元 | 头条金融网",
            "features": {
                "keywords": [
                    "凯莱英",
                    "新股",
                    "挂牌",
                    "暗盘",
                    "下跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "新股速递｜凯莱英6821明挂牌 暗盘早段跌5%报368.6元 | 头条金融网",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022",
            "original_text": "医药生物行业2022年度策略行业策略：核心五问揆情度理 先进制造+创新升级大处落墨",
            "features": {
                "keywords": [
                    "医药生物",
                    "策略",
                    "先进制造",
                    "创新升级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业2022年度策略行业策略：核心五问揆情度理 先进制造+创新升级大处落墨",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-12",
            "original_text": "新股速递｜凯莱英首挂 半日低收3.71%报373.6元 | 头条金融网",
            "features": {
                "keywords": [
                    "凯莱英",
                    "新股",
                    "首挂",
                    "下跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "新股速递｜凯莱英首挂 半日低收3.71%报373.6元 | 头条金融网",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12",
            "original_text": "新股速递｜凯莱英首挂 竞价时段平开於招股价388元 | 头条金融网",
            "features": {
                "keywords": [
                    "凯莱英",
                    "新股",
                    "首挂",
                    "竞价",
                    "平开"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "新股速递｜凯莱英首挂 竞价时段平开於招股价388元 | 头条金融网",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-10",
            "original_text": "凯莱英：将于12月10日开始上市交易",
            "features": {
                "keywords": [
                    "凯莱英",
                    "上市交易"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "凯莱英：将于12月10日开始上市交易",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12",
            "original_text": "传奇生物CAR-T在日本上市；凯莱英公布H股发售价；甘李长效GLP-1受体激动剂在美获批",
            "features": {
                "keywords": [
                    "传奇生物",
                    "CAR-T",
                    "凯莱英",
                    "H股",
                    "甘李",
                    "GLP-1",
                    "获批"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "传奇生物CAR-T在日本上市；凯莱英公布H股发售价；甘李长效GLP-1受体激动剂在美获批",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12",
            "original_text": "医药板块整体下行，相关主题基金密集发行",
            "features": {
                "keywords": [
                    "医药板块",
                    "下行",
                    "主题基金",
                    "发行"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药板块整体下行，相关主题基金密集发行",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]